However, as RCF4 expression also significantly correlates with cell proliferation markers in human NSCLC tissue, the oncogenic effects of RFC4 on cell proliferation, tumorigenicity and tumor metastasis could together contribute to the worse outcomes of NSCLC patient prognosis. Here, RFC4 is linked to non-small cell lung carcinoma.